End of story as Guidant concedes to $4bn cut in Johnson & Johnson offer?
This article was originally published in Clinica
Executive Summary
Just as investors were preparing for a messy courtroom battle between Guidant and Johnson & Johnson, the two companies declared a truce and have laid down their arms. J&J announced on November 15 that the firms have agreed on a revised deal whereby it will acquire Guidant for $21.5bn - almost $4bn less than the original $25.4bn offer.